Cargando…
Oncogenic driver mutations in lung cancer
Lung cancer is a heterogeneous and complex disease. Genomic and transcriptomic profiling of lung cancer not only further our knowledge about cancer initiation and progression, but could also provide guidance on treatment decisions. The fact that targeted treatment is most successful in a subset of t...
Autores principales: | Luo, Susan Y, Lam, David CL |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733434/ https://www.ncbi.nlm.nih.gov/pubmed/27234388 http://dx.doi.org/10.1186/2213-0802-1-6 |
Ejemplares similares
-
Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines
por: Lam, David CL, et al.
Publicado: (2015) -
Oncogenic driver mutations in non-small cell lung cancer: Past, present and future
por: Chevallier, Mathieu, et al.
Publicado: (2021) -
Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era
por: Porta‐Pardo, Eduard, et al.
Publicado: (2020) -
Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients
por: Wang, Rui, et al.
Publicado: (2015) -
Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan
por: Yatabe, Yasushi, et al.
Publicado: (2020)